Prevalence of Oncogenic Human Papillomavirus in Pregnant Adolescents, Association with Colpocytological Changes, Risk Factors and Obstetric Outcomes

Overview

Journal Clinics (Sao Paulo)

Publisher Elsevier

Specialty General Medicine

Date 2022 Nov 3

PMID 36327641

Authors

Henrique Diorio de Souza

Adriana Lippi Waissman

Giselle Rodrigues Mota Diorio

Stela Verzinhasse Peres

Rossana Pulcineli Vieira Francisco

Marco Aurelio Knippel Galletta

Affiliations

Soon will be listed here.

Abstract

Purpose: The authors aim to carry out an investigation on the impact of cervical oncogenic Human Papillomavirus (HPV) detection in pregnant adolescents, to clarify the prevalence and risk factors, considering the importance and lack of data on this topic in Brazil.

Methods: A cross-sectional study was conducted with adolescents receiving prenatal care in a tertiary hospital in São Paulo, Brazil, with routine Pap smear and oncogenic HPV detection test in the uterine cervix. The authors sought to associate the results of these tests with demographic and obstetric variables.

Results: A total of 303 pregnant adolescents whose mean age was 15.30 ± 1.22 years comprised the study subjects. The frequency of high-risk HPV cervical detection was 50.50%. Multivariate analysis revealed that a large number of partners in their lifetime (OR = 1.27) and having a religion (OR = 2.05) were risk factors for cervical detection of oncogenic HPV, while schooling appeared as a protective factor (OR = 0.85). There was an association between this detection and colpocytological alterations, reaching almost 30% of patients, but without association with obstetric and neonatal outcomes.

Conclusion: The prevalence found is one of the highest in Brazil and worldwide. A greater number of partners during their lifetime and having religion were detected as possible factors associated with cervical HPV detection. Detection of cervical HPV-DNA did not influence obstetric and neonatal outcomes. The findings of this study reinforce the need to implement educational measures capable of modifying the incidence of sexually transmitted infections in this population and capable of promoting adherence to HPV vaccination programs.

Citing Articles

The HPV-DNA Test in Pregnancy: A Review of the Literature.

Zagorianakou N, Mitrogiannis I, Konis K, Makrydimas S, Mitrogiannis L, Makrydimas G Cureus. 2023; 15(5):e38619.

PMID: 37284358 PMC: 10240385. DOI: 10.7759/cureus.38619.

References

Tanaka E, Kamizaki S, Quintana S, Pacagnella R, Surita F . Knowledge of Pregnant Adolescents about Human Papillomavirus. Rev Bras Ginecol Obstet. 2019; 41(5):291-297. DOI: 10.1055/s-0039-1688708. View

Lam J, Rebolj M, Dugue P, Bonde J, von Euler-Chelpin M, Lynge E . Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies. J Med Screen. 2014; 21(1):38-50. DOI: 10.1177/0969141314522454. View

Brown C, Leon M, Munoz K, Fagioni A, Amador L, Frain B . Human papillomavirus infection and its association with cervical dysplasia in Ecuadorian women attending a private cancer screening clinic. Braz J Med Biol Res. 2009; 42(7):629-36. DOI: 10.1590/s0100-879x2009000700007. View

Koletic G, Landripet I, Tafro A, Jurkovic L, Milas G, Stulhofer A . Religious faith and sexual risk taking among adolescents and emerging adults: A meta-analytic review. Soc Sci Med. 2021; 291:114488. DOI: 10.1016/j.socscimed.2021.114488. View

Confortini M, Carozzi F, Zappa M, Ventura L, Iossa A, Cariaggi P . Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment. BMC Infect Dis. 2010; 10:157. PMC: 2898819. DOI: 10.1186/1471-2334-10-157. View

Lorincz A, Reid R, Jenson A, Greenberg M, Lancaster W, Kurman R . Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992; 79(3):328-37. DOI: 10.1097/00006250-199203000-00002. View

Koss L, DURFEE G . Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Ann N Y Acad Sci. 1956; 63(6):1245-61. DOI: 10.1111/j.1749-6632.1956.tb32134.x. View

Drolet M, Benard E, Perez N, Brisson M . Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019; 394(10197):497-509. PMC: 7316527. DOI: 10.1016/S0140-6736(19)30298-3. View

Korkidakis A, Bryson P, Jamieson M . Outcomes of a Decade of Routine Cervical Screening in a Canadian Adolescent Obstetrics Clinic. J Obstet Gynaecol Can. 2016; 38(1):51-5. DOI: 10.1016/j.jogc.2015.12.001. View

10.

Smith E, Johnson S, Jiang D, Zaleski S, Lynch C, Brundage S . The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev. 1991; 15(5):397-402. View

11.

Giuliano A, Papenfuss M, Schneider A, Nour M, Hatch K . Risk factors for high-risk type human papillomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev. 1999; 8(7):615-20. View

12.

Branstetter A, McRee A, Reiter P . Correlates of Human Papillomavirus Infection Among a National Sample of Sexual Minority Women. J Womens Health (Larchmt). 2017; 26(9):1004-1011. PMC: 5646741. DOI: 10.1089/jwh.2016.6177. View

13.

Nimrodi M, Kleitman V, Wainstock T, Gemer O, Meirovitz M, Maymon E . The association between cervical inflammation and histologic evidence of HPV in PAP smears and adverse pregnancy outcome in low risk population. Eur J Obstet Gynecol Reprod Biol. 2018; 225:160-165. DOI: 10.1016/j.ejogrb.2018.04.023. View

14.

Rodriguez A, Do T, Goodman M, Schmeler K, Kaul S, Kuo Y . Human Papillomavirus Vaccine Interventions in the U.S.: A Systematic Review and Meta-analysis. Am J Prev Med. 2019; 56(4):591-602. DOI: 10.1016/j.amepre.2018.10.033. View

15.

Schmeink C, Melchers W, Hendriks J, Quint W, Massuger L, Bekkers R . Human papillomavirus detection in pregnant women: a prospective matched cohort study. J Womens Health (Larchmt). 2012; 21(12):1295-301. DOI: 10.1089/jwh.2012.3502. View

16.

Argyri E, Papaspyridakos S, Tsimplaki E, Michala L, Myriokefalitaki E, Papassideri I . A cross sectional study of HPV type prevalence according to age and cytology. BMC Infect Dis. 2013; 13:53. PMC: 3575232. DOI: 10.1186/1471-2334-13-53. View

17.

Beby-Defaux A, Bourgoin A, Ragot S, Battandier D, Lemasson J, Renaud O . Human papillomavirus infection of the cervix uteri in women attending a Health Examination Center of the French social security. J Med Virol. 2004; 73(2):262-8. DOI: 10.1002/jmv.20085. View

18.

Del Rio-Ospina L, Soto-De Leon S, Camargo M, Sanchez R, Mancilla C, Patarroyo M . The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents. PLoS One. 2016; 11(11):e0166502. PMC: 5112891. DOI: 10.1371/journal.pone.0166502. View

19.

Kliucinskas M, Nadisauskiene R, Minkauskiene M . Prevalence and risk factors of HPV infection among high-risk rural and urban Lithuanian women. Gynecol Obstet Invest. 2006; 62(3):173-80. DOI: 10.1159/000093572. View

20.

Ronco G, Ghisetti V, Segnan N, Snijders P, Gillio-Tos A, Meijer C . Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer. 2005; 41(2):297-305. DOI: 10.1016/j.ejca.2004.07.005. View